At Clayco, we believe that every one of our projects is important and play a crucial role in the neighborhoods and communities they are located in. Over the past year, perhaps none of these buildings has taken on a more important role for the entire world than Pfizer’s new research and development facility located just outside of my hometown of St. Louis in Chesterfield, Missouri.

Designed in accordance with LEED sustainability certification standards, Pfizer’s cutting-edge research and development campus includes a combined 295,000 square feet of flexible laboratories and open office space, supporting its development capabilities in biologics and vaccine therapy. This brand-new project has not only become an important hub for Pfizer in the Midwest region, but is also currently the place where every Pfizer COVID-19 vaccine dose originates.

At the Chesterfield facility, they are currently producing the first core element for this truly lifesaving vaccine, and we are so proud that this important stage of the vaccine production process is being carried out at one of Clayco’s projects.

It can't be overstated how proud the Clayco team is to have been a part of a project that is making such an impact in our community and around the world. It’s truly our mantra of “Beyond These Walls” in action.

Pfizer’s new Research and Development Facility is featured here in an NBC Nightly News Exclusive.

It was also featured in an interactive article in The New York Times.